Literature DB >> 20825539

Metabolic syndrome and its components are underdiagnosed in cardiology clinics.

Akira Fujiyoshi1, Mohammad H Murad, Max Luna, Adriana Rosario, Shamsa Ali, David Paniagua, Joanna Molina, Marcos Lopez, Sarah Jacobs, Francisco Lopez-Jimenez.   

Abstract

BACKGROUND: Although metabolic syndrome (MetS) is an important clinical condition, evidence is scarce on how often doctors successfully diagnose this syndrome. AIMS: To assess the extent of doctors' diagnosis of MetS and its components in cardiology outpatient setting and whether such diagnosis affects the way patients are counselled on lifestyle modification.
METHODS: This is a multicentre cross-sectional study on randomly selected clinical notes at ambulatory cardiology clinics in three academic centres in the USA. We abstracted data on cardiovascular risk factors, and examined whether doctors documented a diagnosis of MetS and its components.
RESULTS: Of 511 participants who satisfied our inclusion criteria, the MetS was present in 246 participants (48%). The proportions with which a doctor correctly documented diagnoses were: MetS 9.3% (23/246), obesity 60% (119/197), elevated blood pressure 74% (305/412), elevated fasting glucose 17% (49/291), reduced high density lipoprotein cholesterol 10% (18/190) and elevated triglycerides 20% (32/164). This pattern of diagnoses, less frequent with dyslipidaemia and elevated fasting glucose compared with the rest, was persistently observed regardless of sex, age, and presence or absence of MetS. Those diagnosed were more likely to receive a recommendation of weight loss or increase in physical activity than those undiagnosed: 91% (21/23) versus 37% (82/223) for weight loss, and 83% (19/23) versus 26% (58/223) for increase in physical activity (P < 0.001 for both).
CONCLUSIONS: Our data indicate that MetS and its components are commonly underdiagnosed in cardiology outpatient setting. Better diagnosis may lead to better counselling on lifestyle changes and improvement in the quality of care.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20825539     DOI: 10.1111/j.1365-2753.2010.01371.x

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  4 in total

1.  The Incidence and Determinants of Metabolic Syndrome Amongst a Group of Migrants to Qatar: A Prospective Longitudinal Observational Cohort Study 24-Months Post-Migration.

Authors:  Rana Moustafa Al-Adawi; Kirti Sathyananda Prabhu; Derek Stewart; Cristin Ryan; Hani Abdelaziz; Mohsen Eledrisi; Mohamed Izham Mohamed Ibrahim; Shahab Uddin; Antonella Pia Tonna
Journal:  J Clin Med       Date:  2021-12-22       Impact factor: 4.241

2.  Perirenal Fat Thickness: A Surrogate Marker for Metabolic Syndrome in Chinese Newly Diagnosed Type 2 Diabetes.

Authors:  Xiu Li Guo; Mei Tu; Yang Chen; Wei Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-16       Impact factor: 5.555

3.  Development of a behavior change intervention to improve physical activity adherence in individuals with metabolic syndrome using the behavior change wheel.

Authors:  Dandan Chen; Hui Zhang; Nianqi Cui; Feng Song; Leiwen Tang; Jing Shao; Jingjie Wu; Pingping Guo; Na Liu; Xiyi Wang; Zhihong Ye
Journal:  BMC Public Health       Date:  2022-09-14       Impact factor: 4.135

4.  High intensity interval training exercise-induced physiological changes and their potential influence on metabolic syndrome clinical biomarkers: a meta-analysis.

Authors:  I Serrablo-Torrejon; A Lopez-Valenciano; M Ayuso; E Horton; X Mayo; G Medina-Gomez; G Liguori; A Jimenez
Journal:  BMC Endocr Disord       Date:  2020-11-10       Impact factor: 2.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.